Skye Bioscience, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q3 2012 to Q3 2022

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Skye Bioscience, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q3 2012 to Q3 2022.
Skye Bioscience, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2022 was $0.000.

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2022	$0			Sep 30, 2022	10-Q	2022-11-14
Q2 2014	$26.5K	-$2.14K	-7.46%	Jul 31, 2014	10-Q	2014-09-15
Q1 2014	$35.4K	+$3.35K	+10.4%	Apr 30, 2014	10-Q	2014-06-05
Q4 2013	$34.8K			Jan 31, 2014	10-Q	2014-03-17
Q3 2013	$25.3K	+$18.4K	+267%	Oct 31, 2013	10-Q	2014-09-15
Q2 2013	$28.7K			Jul 31, 2013	10-Q	2013-09-16
Q1 2013	$32.1K			Apr 30, 2013	10-Q	2013-06-27
Q3 2012	$6.91K			Oct 31, 2012	10-K	2014-01-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.